Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Complete Summary

GUIDELINE TITLE

ACR Appropriateness Criteria® low back pain.

BIBLIOGRAPHIC SOURCE(S)

  • Davis PC, Wippold FJ II, Brunberg JA, Cornelius RS, De La Paz RL, Dormont D, Gray L, Jordan JE, Mukherji SK, Seidenwurm DJ, Turski PA, Zimmerman RD, Sloan MA, Expert Panel on Neurologic Imaging. ACR Appropriateness Criteria® low back pain. [online publication]. Reston (VA): American College of Radiology (ACR); 2008. 7 p. [37 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Bradley WG Jr, Seidenwurm DJ, Brunberg JA, Davis PC, DE La Paz RL, Dormont D, Hackney DB, Jordan JE, Karis JP, Mukherji SK, Turski PA, Wippold FJ, Zimmerman RD, McDermott MW, Sloan MA, Expert Panel on Neurologic Imaging. Low back pain. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 7 p. [23 references]

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

COMPLETE SUMMARY CONTENT

 
SCOPE
 METHODOLOGY - including Rating Scheme and Cost Analysis
 RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS
 CONTRAINDICATIONS
 QUALIFYING STATEMENTS
 IMPLEMENTATION OF THE GUIDELINE
 INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

SCOPE

DISEASE/CONDITION(S)

Low back pain with or without radiculopathy

GUIDELINE CATEGORY

Diagnosis
Evaluation

CLINICAL SPECIALTY

Family Practice
Internal Medicine
Neurology
Nuclear Medicine
Orthopedic Surgery
Radiology

INTENDED USERS

Health Plans
Hospitals
Managed Care Organizations
Physicians
Utilization Management

GUIDELINE OBJECTIVE(S)

To evaluate the appropriateness of initial radiologic examinations for patients with low back pain with or without radiculopathy

TARGET POPULATION

Patients with low back pain with or without radiculopathy

INTERVENTIONS AND PRACTICES CONSIDERED

  1. X-ray, lumbar spine
  2. X-ray, myelography, lumbar spine
  3. Nuclear medicine (NUC)
    • Tc-99m bone scan with single photon emission computed tomography (SPECT), spine
    • Technetium (Tc)-99m bone scan, whole body, with optional targeted SPECT, spine
  4. Computed tomography (CT), lumbar spine, without contrast
  5. Myelography and postmyelography CT, lumbar spine
  6. Magnetic resonance imaging (MRI)
    • Lumbar spine, without contrast
    • Lumbar spine, without or with contrast

MAJOR OUTCOMES CONSIDERED

Utility of radiologic examinations in differential diagnosis

METHODOLOGY

METHODS USED TO COLLECT/SELECT EVIDENCE

Searches of Electronic Databases

DESCRIPTION OF METHODS USED TO COLLECT/SELECT THE EVIDENCE

The guideline developer performed literature searches of peer-reviewed medical journals, and the major applicable articles were identified and collected.

NUMBER OF SOURCE DOCUMENTS

Not stated

METHODS USED TO ASSESS THE QUALITY AND STRENGTH OF THE EVIDENCE

Weighting According to a Rating Scheme (Scheme Not Given)

RATING SCHEME FOR THE STRENGTH OF THE EVIDENCE

Not stated

METHODS USED TO ANALYZE THE EVIDENCE

Systematic Review with Evidence Tables

DESCRIPTION OF THE METHODS USED TO ANALYZE THE EVIDENCE

One or two topic leaders within a panel assume the responsibility of developing an evidence table for each clinical condition, based on analysis of the current literature. These tables serve as a basis for developing a narrative specific to each clinical condition.

METHODS USED TO FORMULATE THE RECOMMENDATIONS

Expert Consensus (Delphi)

DESCRIPTION OF METHODS USED TO FORMULATE THE RECOMMENDATIONS

Since data available from existing scientific studies are usually insufficient for meta-analysis, broad-based consensus techniques are needed to reach agreement in the formulation of the appropriateness criteria. The American College of Radiology (ACR) Appropriateness Criteria panels use a modified Delphi technique to arrive at consensus. Serial surveys are conducted by distributing questionnaires to consolidate expert opinions within each panel. These questionnaires are distributed to the participants along with the evidence table and narrative as developed by the topic leader(s). Questionnaires are completed by the participants in their own professional setting without influence of the other members. Voting is conducted using a scoring system from 1 to 9, indicating the least to the most appropriate imaging examination or therapeutic procedure. The survey results are collected, tabulated in anonymous fashion, and redistributed after each round. A maximum of three rounds is conducted and opinions are unified to the highest degree possible. Eighty percent agreement is considered a consensus. This modified Delphi technique enables individual, unbiased expression, is economical, easy to understand, and relatively simple to conduct.

If consensus cannot be reached by the Delphi technique, the panel is convened and group consensus techniques are utilized. The strengths and weaknesses of each test or procedure are discussed and consensus reached whenever possible. If "No consensus" appears in the rating column, reasons for this decision are added to the comment sections.

RATING SCHEME FOR THE STRENGTH OF THE RECOMMENDATIONS

Not applicable

COST ANALYSIS

A formal cost analysis was not performed and published cost analyses were not reviewed.

METHOD OF GUIDELINE VALIDATION

Internal Peer Review

DESCRIPTION OF METHOD OF GUIDELINE VALIDATION

Criteria developed by the Expert Panels are reviewed by the American College of Radiology (ACR) Committee on Appropriateness Criteria.

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

ACR Appropriateness Criteria®

Clinical Condition: Low Back Pain

Variant 1: Uncomplicated acute low back pain and/or radiculopathy, nonsurgical presentation. No red flags. (Red flags defined in the text below.)

Radiologic Procedure Rating Comments RRL*
MRI lumbar spine without contrast 2   None
X-ray lumbar spine 2   Med
Myelography and postmyelography CT lumbar spine 2 In some cases postinjection CT imaging may be done without myelography. High
X-ray myelography lumbar spine 2   Med
NUC Tc-99m bone scan with SPECT spine 2   Med
CT lumbar spine without contrast 2   Med
MRI lumbar spine without and with contrast 2   None
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 2: Low velocity trauma, osteoporosis, and/or age > 70.

Radiologic Procedure Rating Comments RRL*
MRI lumbar spine without contrast 8   None
CT lumbar spine without contrast 6 MRI preferred. CT useful if MRI is contraindicated or unavailable, and/or for problem solving. Med
X-ray lumbar spine 6   Med
NUC Tc-99 bone scan with SPECT spine 4   Med
MRI lumbar spine without and with contrast 3   None
Myelography and postmyelography CT lumbar spine 1 In some cases postinjection CT imaging may be done without myelography. High
X-ray myelography lumbar spine 1   Med
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 3: Suspicion of cancer, infection, or immunosuppression.

Radiologic Procedure Rating Comments RRL*
MRI lumbar spine without and with contrast 8 See comments regarding contrast in the text below under "Anticipated Exceptions." None
CT lumbar spine without contrast 6 MRI preferred. CT useful if MRI is contraindicated or unavailable, and/or for problem solving. Med
X-ray lumbar spine 5   Med
NUC Tc-99m bone scan whole body with optional targeted SPECT spine 5   Med
X-ray myelography lumbar spine 2   Med
Myelography and postmyelography CT lumbar spine 2 In some cases postinjection CT imaging may be done without myelography. High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 4: Low back pain and/or radiculopathy, surgery or intervention candidate.

Radiologic Procedure Rating Comments RRL*
MRI lumbar spine without contrast 8   None
CT lumbar spine without contrast 5 MRI preferred. CT useful if MRI contraindicated or unavailable, and/or for problem solving. Med
MRI lumbar spine without and with contrast 5 Indicated if noncontrast MRI is nondiagnostic or indeterminate. See comments regarding contrast in the text below under "Anticipated Exceptions." None
Myelography and postmyelography CT lumbar spine 5 MRI preferred. May be indicated if MRI is contraindicated or nondiagnostic. In some cases postinjection CT imaging may be done without myelography. High
X-ray lumbar spine 4 Usually not sufficient for decision making without MR and/or CT imaging. Med
NUC Tc-99m bone scan with SPECT spine 4 May be particularly useful for facet arthropathy, stress fracture, and spondylolysis. Med
X-ray myelography lumbar spine 2   Med
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 5: Prior lumbar surgery.

Radiologic Procedure Rating Comments RRL*
MRI lumbar spine without and with contrast 8 Differentiate disc versus scar. See comments regarding contrast in the text below under "Anticipated Exceptions." None
CT lumbar spine without contrast 6 Most useful in postfusion patients or when MRI is contraindicated or indeterminate. Med
MRI lumbar spine without contrast 6 Contrast often necessary None
Myelography and postmyelography CT lumbar spine 5 In some cases postinjection CT imaging may be done without myelography. High
X-ray lumbar spine 5 Flex/extension may be useful. Med
NUC Tc-99m bone scan with SPECT spine 5 Helps detect and localize painful pseudoarthrosis. Med
X-ray myelography lumbar spine 2   Med
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 6: Cauda equina syndrome.

Radiologic Procedure Rating Comments RRL*
MRI lumbar spine without contrast 9 Use of contrast depends on clinical circumstances. None
MRI lumbar spine without and with contrast 8 Use of contrast depends on clinical circumstances. See comments regarding contrast in the text below under "Anticipated Exceptions." None
Myelography and postmyelography CT lumbar spine 6 Useful if MRI is nondiagnostic or contraindicated. In some cases postinjection CT imaging may be done without myelography. High
CT lumbar spine with or without contrast 5 May be indicated if MRI is confusing or contraindicated and myelography is not feasible. Use of contrast depends on clinical circumstances. Med
X-ray lumbar spine 4   Med
NUC Tc-99m bone scan with SPECT spine 2   Med
X-ray myelography lumbar spine 2   Med
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Summary of Literature Review

Acute low back pain (LBP) with or without radiculopathy is one of the most common health problems in the United States and is the leading cause of disability for persons younger than age 45. The cost of evaluating and treating acute LBP runs into billions of dollars annually, not including time lost from work.

Because of the high prevalence and high cost of dealing with this problem, government agencies have sponsored extensive studies that are now part of the growing body of literature on this subject. One of the earlier comprehensive studies was carried out in Quebec and was reported in the journal Spine in 1987. The U.S. Department of Health and Human Services convened a 23-member multidisciplinary panel of experts to review all of the literature on this subject, grade it, and develop a "Clinical Practice Guideline," which was published in December 1994. States have also convened similar panels in recent years, largely because of the rapidly rising workers' compensation claim burden being imposed on state budgets by LBP management.

It is now clear from the above studies and others that uncomplicated acute LBP or radiculopathy is a benign, self-limited condition that does not warrant any imaging studies. The vast majority of these patients are back to their usual activities within 30 days. The challenge for the clinician, therefore, is to distinguish that small segment within this large patient population that should be evaluated further because of suspicion of a more serious problem.

Indications of a more complicated status, often termed "red flags," include the following:

  1. Recent significant trauma, or milder trauma, age >50
  2. Unexplained weight loss
  3. Unexplained fever
  4. Immunosuppression
  5. History of cancer
  6. Intravenous (IV) drug use
  7. Prolonged use of corticosteroids, osteoporosis
  8. Age >70
  9. Focal neurologic deficit with progressive or disabling symptoms
  10. Duration longer than 6 weeks

Radiographs

Radiographs are recommended when any of the above red flags are present. Lumbar radiographs may be sufficient for the initial evaluation of the following red flags, with further imaging indicated for treatment planning: if findings are abnormal or inconclusive.

  1. Recent significant trauma (at any age)
  2. Osteoporosis
  3. Age >70

The initial evaluation of the LBP patient may also require further imaging if other red flags such as suspicion of cancer or infection are present.

Isotope Bone Scan

The role of the isotope bone scan in patients with acute LBP has changed in recent years with the wide availability of magnetic resonance imaging (MRI) and especially contrast-enhanced MRI. The bone scan is a moderately sensitive test for detecting the presence of tumor, infection, or occult fractures of the vertebrae but not for specifying the diagnosis. For spondylolysis or stress fracture in athletes, bone scintigraphy with single photon emission computed tomography (SPECT), followed by limited computed tomography (CT) if scintigraphy is positive, is more sensitive than MRI. Bone scintigraphy with SPECT can be useful to identify symptomatic facet disease in patients treated with facet injection.

High-resolution isotope imaging, including SPECT, may localize the source of pain in patients with articular facet osteoarthritis prior to therapeutic facet injection. Similar scans may be helpful in detecting and localizing the site of painful pseudoarthrosis in patients following lumbar spinal fusion. The test is contraindicated in pregnancy.

Plain and contrast-enhanced MRI has the ability to demonstrate inflammatory, neoplastic, and most traumatic lesions as well as show anatomic detail not available on isotope studies. Gadolinium-enhanced MRI reliably shows the presence and extent of spinal infection, and is useful in assessing therapy. MRI has therefore taken over the role of the isotope scan in many cases where the location of the lesion is known. The isotope scan remains invaluable when a survey of the entire skeleton is indicated (e.g., for metastatic disease).

Magnetic Resonance Imaging, Computed Tomography, Myelography, Myelography/CT

Uncomplicated acute LBP and/or radiculopathy (no red flags) do not warrant the use of any of these imaging studies. The early indiscriminate use of expensive imaging procedures in this common clinical setting has caused large increases in worker's compensation costs and in some cases has led to the perception that CT and MRI of the lumbar spine are not worth the cost. Adding to this controversy is the fact that nonspecific lumbar disc abnormalities are common and can be demonstrated readily on myelography, CT, and MRI, even in asymptomatic patients.

The appropriate use of these imaging procedures is an important challenge that has been extensively addressed in the major reviews referenced herein (see the original guideline). For example, LBP complicated by "red flags" suggesting infection or tumor may justify early use of CT or MRI even if radiographs are negative. The most common indication for the use of these imaging procedures, however, is the clinical setting of LBP complicated by radiating pain (radiculopathy, sciatica) or cauda equina syndrome (bilateral leg weakness, urinary retention, saddle anesthesia), usually due to herniated disc and/or canal stenosis.

Magnetic Resonance Imaging

MRI of the lumbar spine has become the initial imaging modality of choice in complicated LBP, displacing myelography and CT in recent years. Multidisciplinary agreement on terminology facilitates reporting of MRI findings. Although disc abnormalities are common on MRI in asymptomatic persons, acute back pain with radiculopathy suggests the presence of demonstrable nerve root compression on MRI. MRI findings of Modic endplate change, anterolisthesis, or disc extrusion are more strongly associated with low back pain than disc degeneration without endplate change. A randomized controlled trial showed that depiction of stenosis and/or nerve root compression on MRI in the first 48 hours after acute back pain or radiculopathy onset did not affect outcome after 6 weeks of conservative management. MRI is particularly efficacious for detecting "red flag" diagnoses, particularly using the short tan inversion recovery (STIR) and fat-saturated T2 fast-spin-echo sequences. MR with contrast is useful for suspected infection and neoplasia. In postop patients, enhanced MRI allows distinction between disc and scar when tissue extends beyond the interspace.

Computed Tomography

CT scans provide superior bone detail but are not quite as useful in depicting disc protrusions when compared with multiplanar MRI. With the added value associated with high-quality reformatted sagittal and coronal plane images, CT is useful for depicting spondylolysis, pseudoarthrosis, scoliosis, and for post-surgical evaluation of bone graft integrity, surgical fusion, and instrumentation.

Myelography/CT

"Plain" myelography was the mainstay of lumbar herniated disc diagnosis for decades. It is now usually combined with postmyelography CT. The combined study is complementary to plain CT or MRI and occasionally more accurate in diagnosing disc herniation, but it suffers the disadvantage of requiring lumbar puncture and contrast injection. It may also be useful in surgical planning.

Thermography, Discography, CT Discography

Expert panels have agreed that these imaging modalities are either too nonspecific (thermography) or carry additional risk (discography) that is not warranted in view of the efficacy of other less invasive imaging procedures. When other studies fail to localize the cause of pain, discography may occasionally be helpful. Although the images often depict nonspecific aging or degenerative changes, the injection itself may reproduce the patient's pain, which may have diagnostic value.

Anticipated Exceptions

Nephrogenic systemic fibrosis (NSF, also known as nephrogenic fibrosing dermopathy) was first identified in 1997 and has recently generated substantial concern among radiologists, referring doctors and lay people. Until the last few years, gadolinium-based MR contrast agents were widely believed to be almost universally well tolerated, extremely safe and non-nephrotoxic, even when used in patients with impaired renal function. All available experience suggests that these agents remain generally very safe, but recently some patients with renal failure who have been exposed to gadolinium contrast agents (the percentage is unclear) have developed NSF, a syndrome that can be fatal. Further studies are necessary to determine what the exact relationships are between gadolinium-containing contrast agents, their specific components and stoichiometry, patient renal function and NSF. Current theory links the development of NSF to the administration of relatively high doses (e.g., >0.2mM/kg) and to agents in which the gadolinium is least strongly chelated. The U.S. Food and Drug Administration (FDA) has recently issued a "black box" warning concerning these contrast agents (http://www.fda.gov/cder/drug/InfoSheets/HCP/gcca_200705HCP.pdf).

This warning recommends that, until further information is available, gadolinium contrast agents should not be administered to patients with either acute or significant chronic kidney disease (estimated glomerular filtration rate [GFR] <30 mL/min/1.73m2), recent liver or kidney transplant or hepato-renal syndrome, unless a risk-benefit assessment suggests that the benefit of administration in the particular patient clearly outweighs the potential risk(s).

Abbreviations

  • CT, computed tomography
  • Med, medium
  • MRI, magnetic resonance imaging
  • NUC, nuclear medicine
  • SPECT, single photon emission computed tomography
  • Tc, technetium

Relative Radiation Level Effective Dose Estimated Range
None 0
Minimal <0.1 mSv
Low 0.1-1 mSv
Medium 1-10 mSv
High 10-100 mSv

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based on analysis of the current literature and expert panel consensus.

BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS

POTENTIAL BENEFITS

Selection of appropriate radiologic imaging procedures for evaluation of patients with low back pain (LBP) with or without radiculopathy

POTENTIAL HARMS

  • The early indiscriminate use of expensive imaging procedures in this common clinical setting has caused large increases in worker's compensation costs and in some cases has led to the perception that computed tomography and magnetic resonance imaging of the lumbar spine is not worth the cost. The challenge for the clinician, therefore, is to distinguish that small segment within this large patient population that should be evaluated further because of suspicion of a more serious problem.
  • Some patients with renal failure who have been exposed to gadolinium contrast agents (the percentage is unclear) have developed nephrogenic systemic fibrosis (NSF), a syndrome that can be fatal. The U.S. Food and Drug Administration (FDA) has recently issued a "black box" warning concerning these contrast agents. This warning recommends that, until further information is available, gadolinium contrast agents should not be administered to patients with either acute or significant chronic kidney disease (estimated glomerular filtration rate [GFR] <30 mL/min/1.73m2), recent liver or kidney transplant or hepato-renal syndrome, unless a risk-benefit assessment suggests that the benefit of administration in the particular patient clearly outweighs the potential risk(s).

Relative Radiation Level (RRL)

Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level indication has been included for each imaging examination. The RRLs are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure. Additional information regarding radiation dose assessment for imaging examinations can be found in the American College of Radiology (ACR) Appropriateness Criteria® Radiation Dose Assessment Introduction document (see "Availability of Companion Documents" field).

CONTRAINDICATIONS

CONTRAINDICATIONS

Isotope bone scan is contraindicated in pregnancy.

QUALIFYING STATEMENTS

QUALIFYING STATEMENTS

An American College of Radiology (ACR) Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient's clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those exams generally used for evaluation of the patient's condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the U.S. Food and Drug Administration (FDA) have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination.

IMPLEMENTATION OF THE GUIDELINE

DESCRIPTION OF IMPLEMENTATION STRATEGY

An implementation strategy was not provided.

IMPLEMENTATION TOOLS

Personal Digital Assistant (PDA) Downloads

For information about availability, see the "Availability of Companion Documents" and "Patient Resources" fields below.

INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES

IOM CARE NEED

Getting Better

IOM DOMAIN

Effectiveness

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Davis PC, Wippold FJ II, Brunberg JA, Cornelius RS, De La Paz RL, Dormont D, Gray L, Jordan JE, Mukherji SK, Seidenwurm DJ, Turski PA, Zimmerman RD, Sloan MA, Expert Panel on Neurologic Imaging. ACR Appropriateness Criteria® low back pain. [online publication]. Reston (VA): American College of Radiology (ACR); 2008. 7 p. [37 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1996 (revised 2008)

GUIDELINE DEVELOPER(S)

American College of Radiology - Medical Specialty Society

SOURCE(S) OF FUNDING

The American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria®.

GUIDELINE COMMITTEE

Committee on Appropriateness Criteria, Expert Panel on Neurologic Imaging

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Panel Members: Patricia C. Davis, MD; Franz J. Wippold II, MD; James A. Brunberg, MD; Rebecca S. Cornelius, MD; Robert L. De La Paz, MD; Pr. Didier Dormont; Linda Gray, MD; John E. Jordan, MD; Suresh Kumar Mukherji, MD; David J. Seidenwurm, MD; Patrick A. Turski, MD; Robert D. Zimmerman, MD; Michael A. Sloan, MD, MS

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Bradley WG Jr, Seidenwurm DJ, Brunberg JA, Davis PC, DE La Paz RL, Dormont D, Hackney DB, Jordan JE, Karis JP, Mukherji SK, Turski PA, Wippold FJ, Zimmerman RD, McDermott MW, Sloan MA, Expert Panel on Neurologic Imaging. Low back pain. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 7 p. [23 references]

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American College of Radiology (ACR) Web site.

ACR Appropriateness Criteria® Anytime, Anywhere™ (PDA application). Available from the ACR Web site.

Print copies: Available from the American College of Radiology, 1891 Preston White Drive, Reston, VA 20191. Telephone: (703) 648-8900.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on July 31, 2001. The information was verified by the guideline developer as of August 24, 2001. This summary was updated by ECRI on March 28, 2006. This summary was updated by ECRI Institute on May 17, 2007 following the U.S. Food and Drug Administration (FDA) advisory on Gadolinium-based contrast agents. This summary was updated by ECRI Institute on June 20, 2007 following the U.S. Food and Drug Administration (FDA) advisory on gadolinium-based contrast agents. This summary was updated by ECRI Institute on July 1, 2009.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo